Wu (Department of Pathology and Laboratory Medicine, Hartford Hospital) presents work by international authorities in clinical chemistry and laboratory medicine on the uses of cardiac markers when treating coronary artery diseases and how they may used in a clinical setting. For this second edition, there is new material on the use of natriuretic peptides for congestive heart failure, and new ischemic markers such as CRP, fatty acid binding protein, oxidized LDL, whole blood choline, and genetic polymorphisms are introduced. Annotation (c)2003 Book News, Inc., Portland, OR (booknews.com).